Hosted on MSN5d
Windtree Therapeutics Highlights Istaroxime’s Promise for Cardiogenic Shock
Windtree Therapeutics, Inc. (NasdaqCM: WINT) recently showcased promising data on istaroxime, an investigational treatment ...
Medical Xpress23d
Cardiogenic shock team cuts time to diagnosis by half
A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more than half, according to a study published in Critical Care Nurse.
Zacks Small Cap Research on MSN2mon
WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones
Cardiogenic shock is an area of extreme unmet need ... The New York Heart Association (NYHA) classification of heart failure ...
TCTMD13d
ACC Offers ‘Practical Document’ for Myocarditis Diagnosis and Care
In the absence of full guidelines, this expert consensus decision pathway gives practical advice for clinicians.